The FDA Has Issued Increased Warnings for Depakote Use During Pregnancy

“The FDA released a MedWatch safety alert today to increase the warnings for valproate products, such as Depakote® (divalproex sodium), Depacon® (valproate sodium), Depakene® (valproic acid), Stavzor® (valproic acid), and their generics. Valproate products are approved for the treatment of epilepsy, manic episodes associated with bipolar disorder, and prevention of migraine headaches. However, today the FDA warned…”